Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Butler

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Natural Product Reports|September 11, 2014
Natural product and natural product derived drugs in clinical trialsMark S Butler, Avril A B Robertson, Matthew A Cooper
Journal of Natural Products|August 24, 2002
Three new pyridoacridine type alkaloids from a singaporean ascidianNilar Nilar, Philip J Sidebottom, Brad K Carté, et al.
Current Drug Targets|June 6, 2012
Resolving biofilm infections: current therapy and drug discovery strategiesMax V Ranall, Mark S Butler, Mark A Blaskovich, et al.
Current Opinion in Microbiology|June 6, 2016
Old dogs and new tricks in antimicrobial discoveryMark S Butler, Mark At Blaskovich, Jeremy G Owen, et al.
Phytochemistry|October 17, 2003
Phenolic derivatives from Wigandia urens with weak activity against the chemokine receptor CCR5Shugeng Cao, Christine Rossant, Siewbee Ng, et al.
Bioinformatics Advances|June 5, 2023
FLONE: fully Lorentz network embedding for inferring novel drug targetsYang Yue, David McDonald, Luoying Hao, et al.
The Journal of Antibiotics|June 8, 2023
Antibiotics in the clinical pipeline as of December 2022Mark S Butler, Ian R Henderson, Robert J Capon, et al.
The Journal of Antibiotics|November 7, 2023
Correction: Antibiotics in the clinical pipeline as of December 2022Mark S Butler, Ian R Henderson, Robert J Capon, et al.
Natural Product Reports|September 9, 2025
Natural product-derived compounds in clinical trials and drug approvalsMark S Butler, Robert J Capon, Mark A T Blaskovich, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2014
Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in Staphylococcus aureusMu Cheng, Johnny X Huang, Soumya Ramu, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Natural Product Reports|September 11, 2014
Natural product and natural product derived drugs in clinical trialsMark S Butler, Avril A B Robertson, Matthew A Cooper
Journal of Natural Products|August 24, 2002
Three new pyridoacridine type alkaloids from a singaporean ascidianNilar Nilar, Philip J Sidebottom, Brad K Carté, et al.
Current Drug Targets|June 6, 2012
Resolving biofilm infections: current therapy and drug discovery strategiesMax V Ranall, Mark S Butler, Mark A Blaskovich, et al.
Current Opinion in Microbiology|June 6, 2016
Old dogs and new tricks in antimicrobial discoveryMark S Butler, Mark At Blaskovich, Jeremy G Owen, et al.
Phytochemistry|October 17, 2003
Phenolic derivatives from Wigandia urens with weak activity against the chemokine receptor CCR5Shugeng Cao, Christine Rossant, Siewbee Ng, et al.
Bioinformatics Advances|June 5, 2023
FLONE: fully Lorentz network embedding for inferring novel drug targetsYang Yue, David McDonald, Luoying Hao, et al.
The Journal of Antibiotics|June 8, 2023
Antibiotics in the clinical pipeline as of December 2022Mark S Butler, Ian R Henderson, Robert J Capon, et al.
The Journal of Antibiotics|November 7, 2023
Correction: Antibiotics in the clinical pipeline as of December 2022Mark S Butler, Ian R Henderson, Robert J Capon, et al.
Natural Product Reports|September 9, 2025
Natural product-derived compounds in clinical trials and drug approvalsMark S Butler, Robert J Capon, Mark A T Blaskovich, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2014
Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in Staphylococcus aureusMu Cheng, Johnny X Huang, Soumya Ramu, et al.
Pageof 12